↓ Skip to main content

Effects of Panax Ginseng Extract in Patients with Fibromyalgia: A 12-week, Randomized, Double-blind, Placebo-controlled Trial

Overview of attention for article published in Revista Brasileira de Psiquiatria, February 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
159 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of Panax Ginseng Extract in Patients with Fibromyalgia: A 12-week, Randomized, Double-blind, Placebo-controlled Trial
Published in
Revista Brasileira de Psiquiatria, February 2013
DOI 10.1016/j.rbp.2013.01.004
Pubmed ID
Authors

Alessandra S. Braz, Liana Clébia S. Morais, Ana Patríca Paula, Margareth F.F.M. Diniz, Reinaldo N. Almeida

Abstract

The purpose of the study was to evaluate the efficacy of an extract of Panax ginseng in patients with fibromyalgia. A randomized, double-blind, controlled clinical trial was carried out over 12 weeks to compare the effects of P. ginseng (100 mg/d) with amitriptyline (25 mg/d) and placebo in 38 patients with fibromyalgia: 13 in Group I (amitriptyline), 13 in Group II (placebo), and 12 in Group III (P. ginseng). Ratings on the Visual Analogue Scale (VAS) revealed a reduction in pain in the P. ginseng group (p < .0001), an improvement in fatigue (p < .0001) and an improvement in sleep (p < .001), with respect to baseline characteristics, but there were no differences between the three groups. With respect to anxiety, improvements occurred in the P. ginseng group compared to baseline (p < .0001); however, amitriptyline treatment resulted in significantly greater improvements (p < .05). P. ginseng reduced the number of tender points and improved patients' quality of life (using the Fibromyalgia Impact Questionnaire - FIQ); however, there were no differences between groups. The beneficial effects experienced by patients for all parameters suggest a need for further studies to be performed on the tolerability and efficacy of this phytotherapic as a complementary therapy for fibromyalgia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 2%
Australia 3 2%
Unknown 153 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 40 25%
Student > Master 21 13%
Student > Ph. D. Student 14 9%
Other 10 6%
Researcher 9 6%
Other 20 13%
Unknown 45 28%
Readers by discipline Count As %
Medicine and Dentistry 51 32%
Nursing and Health Professions 17 11%
Psychology 10 6%
Agricultural and Biological Sciences 6 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 21 13%
Unknown 48 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2023.
All research outputs
#2,378,186
of 25,756,911 outputs
Outputs from Revista Brasileira de Psiquiatria
#74
of 907 outputs
Outputs of similar age
#22,824
of 293,176 outputs
Outputs of similar age from Revista Brasileira de Psiquiatria
#1
of 20 outputs
Altmetric has tracked 25,756,911 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 907 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.